144 related articles for article (PubMed ID: 22960238)
1. β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients.
Song HJ; Lee J; Kim YJ; Jung SY; Kim HJ; Choi NK; Park BJ
Bone; 2012 Dec; 51(6):1008-15. PubMed ID: 22960238
[TBL] [Abstract][Full Text] [Related]
2. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
[TBL] [Abstract][Full Text] [Related]
3. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
Liou YS; Ma T; Tien L; Lin CM; Jong GP
Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.
Botteri E; Munzone E; Rotmensz N; Cipolla C; De Giorgi V; Santillo B; Zanelotti A; Adamoli L; Colleoni M; Viale G; Goldhirsch A; Gandini S
Breast Cancer Res Treat; 2013 Aug; 140(3):567-75. PubMed ID: 23912960
[TBL] [Abstract][Full Text] [Related]
5. beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures.
Reid IR; Gamble GD; Grey AB; Black DM; Ensrud KE; Browner WS; Bauer DC
J Bone Miner Res; 2005 Apr; 20(4):613-8. PubMed ID: 15765180
[TBL] [Abstract][Full Text] [Related]
6. The risk of hip fracture after initiating antihypertensive drugs in the elderly.
Butt DA; Mamdani M; Austin PC; Tu K; Gomes T; Glazier RH
Arch Intern Med; 2012 Dec; 172(22):1739-44. PubMed ID: 23165923
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers are associated with increased risk of first cardiovascular events in non-diabetic hypertensive elderly patients.
Brouwers FM; Courteau J; Cohen AA; Farand P; Cloutier L; Asghari S; Vanasse A
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1139-46. PubMed ID: 25045055
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis.
Bangalore S; Wild D; Parkar S; Kukin M; Messerli FH
J Am Coll Cardiol; 2008 Sep; 52(13):1062-72. PubMed ID: 18848139
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study.
Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T
Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614
[TBL] [Abstract][Full Text] [Related]
10. β-Adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects.
Toulis KA; Hemming K; Stergianos S; Nirantharakumar K; Bilezikian JP
Osteoporos Int; 2014 Jan; 25(1):121-9. PubMed ID: 24114396
[TBL] [Abstract][Full Text] [Related]
11. Why beta-blockers should not be used as first choice in uncomplicated hypertension.
De Caterina AR; Leone AM
Am J Cardiol; 2010 May; 105(10):1433-8. PubMed ID: 20451690
[TBL] [Abstract][Full Text] [Related]
12. Use of beta-blockers and risk of fractures.
Schlienger RG; Kraenzlin ME; Jick SS; Meier CR
JAMA; 2004 Sep; 292(11):1326-32. PubMed ID: 15367554
[TBL] [Abstract][Full Text] [Related]
13. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.
Kannegaard PN; van der Mark S; Eiken P; Abrahamsen B
Age Ageing; 2010 Mar; 39(2):203-9. PubMed ID: 20075035
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database.
Bokrantz T; Schiöler L; Boström KB; Kahan T; Mellström D; Ljungman C; Hjerpe P; Hasselström J; Manhem K
J Hypertens; 2020 Jan; 38(1):167-175. PubMed ID: 31568060
[TBL] [Abstract][Full Text] [Related]
15. Use of beta-blockers for uncomplicated hypertension in the elderly: a cause for concern.
Tu K; Campbell NR; Chen Z; McAlister FA
J Hum Hypertens; 2007 Apr; 21(4):271-5. PubMed ID: 17287848
[TBL] [Abstract][Full Text] [Related]
16. Residual lifetime risk of fractures in women and men.
Nguyen ND; Ahlborg HG; Center JR; Eisman JA; Nguyen TV
J Bone Miner Res; 2007 Jun; 22(6):781-8. PubMed ID: 17352657
[TBL] [Abstract][Full Text] [Related]
17. Risk of fractures in subjects with antihypertensive medications: A nationwide claim study.
Choi HJ; Park C; Lee YK; Ha YC; Jang S; Shin CS
Int J Cardiol; 2015 Apr; 184():62-67. PubMed ID: 25697872
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy.
Corrao G; Zambon A; Parodi A; Poluzzi E; Baldi I; Merlino L; Cesana G; Mancia G
J Hypertens; 2008 Apr; 26(4):819-24. PubMed ID: 18327094
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study.
Pasco JA; Henry MJ; Sanders KM; Kotowicz MA; Seeman E; Nicholson GC;
J Bone Miner Res; 2004 Jan; 19(1):19-24. PubMed ID: 14753732
[TBL] [Abstract][Full Text] [Related]
20. Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden.
Carlsson AC; Wändell P; Sundquist K; Johansson SE; Sundquist J
Hypertens Res; 2014 Jun; 37(6):553-9. PubMed ID: 24599014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
